Form CORRESP - Correspondence:
SEC Accession No. 0001641172-25-003293
Filing Date
2025-04-08
Accepted
2025-04-08 21:07:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10894
2 formcorresp_001.jpg GRAPHIC 3167
  Complete submission text file 0001641172-25-003293.txt   16401
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)